Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Isabelle Van-Praagh"'
Autor:
Judith Passildas‐Jahanmohan, Jean‐Christophe Eymard, Mélanie Pouget, Fabrice Kwiatkowski, Isabelle Van Praagh, Laurent Savareux, Marc Atger, Xavier Durando, Catherine Abrial, Damien Richard, Angeline Ginzac Couvé, Emilie Thivat, Brigitte Monange, Philippe Chollet, Hakim Mahammedi
Publikováno v:
Cancer Medicine, Vol 10, Iss 7, Pp 2332-2340 (2021)
Abstract Background Metastatic castration‐resistant prostate cancer (mCRPC) patients have a poor prognosis, and curcumin is known to have antineoplastic properties. On the basis of previous phase I and phase II studies, we investigated whether the
Externí odkaz:
https://doaj.org/article/dec34d0104454f589f682507b2d27cc5
Autor:
Philippe Chollet, Xavier Durando, Isabelle Van Praagh-Doreau, Marie-Ange Mouret-Reynier, Fabrice Kwiatkowski, Hervé Devaud, Régine Chevrier, Emilie Thivat, Pascale Dubray-Longeras, Camille Poirier, Laure Vacher
Publikováno v:
Supportive Care in Cancer
Supportive Care in Cancer, 2020, 28 (7), pp.3313-3322. ⟨10.1007/s00520-019-05144-x⟩
Supportive Care in Cancer, Springer Verlag (Germany), 2020, 28 (7), pp.3313-3322. ⟨10.1007/s00520-019-05144-x⟩
Supportive Care in Cancer, 2020, 28 (7), pp.3313-3322. ⟨10.1007/s00520-019-05144-x⟩
Supportive Care in Cancer, Springer Verlag (Germany), 2020, 28 (7), pp.3313-3322. ⟨10.1007/s00520-019-05144-x⟩
A patient non-adherence with oral anticancer agents is a well-recognized barrier to effective treatment. The aim of this prospective study was to evaluate the efficacy of a therapeutic education program among non-adherent patients treated with Capeci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c445be8c371154d24c21dcf5f7df95b
https://doi.org/10.1007/s00520-019-05144-x
https://doi.org/10.1007/s00520-019-05144-x
Autor:
Pierre Soubeyran, Carine Bellera, Jean Goyard, Damien Heitz, Hervé Curé, Hubert Rousselot, Gilles Albrand, Véronique Servent, Olivier Saint Jean, Isabelle van Praagh, Jean-Emmanuel Kurtz, Stéphane Périn, Jean-Luc Verhaeghe, Catherine Terret, Christophe Desauw, Véronique Girre, Cécile Mertens, Simone Mathoulin-Pélissier, Muriel Rainfray
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e115060 (2014)
Geriatric Assessment is an appropriate method for identifying older cancer patients at risk of life-threatening events during therapy. Yet, it is underused in practice, mainly because it is time- and resource-consuming. This study aims to identify th
Externí odkaz:
https://doaj.org/article/a536cf37e8894c099973422c3907d4e0
Autor:
Yves-Jean Bignon, Isabelle Van Praagh-Doreau, Marie-Ange Mouret-Reynier, Fabrice Kwiatkowski, Marie-Paule Vasson, Martine Duclos, Sylvie Jouvency, Armelle Travade, Adrien Rossary
Publikováno v:
Journal of Oncology
Journal of Oncology, Hindawi Publishing Corporation, 2020, 2020, pp.4181850. ⟨10.1155/2020/4181850⟩
Journal of Oncology, 2020, 2020, pp.4181850. ⟨10.1155/2020/4181850⟩
Journal of Oncology, Vol 2020 (2020)
Journal of Oncology, Hindawi Publishing Corporation, 2020, 2020, pp.4181850. ⟨10.1155/2020/4181850⟩
Journal of Oncology, 2020, 2020, pp.4181850. ⟨10.1155/2020/4181850⟩
Journal of Oncology, Vol 2020 (2020)
A growing knowledge highlights the strong benefit of regular physical activity in the management of breast cancer patients, but few studies have considered biological parameters in their outcomes. In the prospective randomised trial after breast canc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0401a90559661827a51f6bb84ec0fa4
https://hal.archives-ouvertes.fr/hal-02882190/file/2020_Vasson_J_Oncology.pdf
https://hal.archives-ouvertes.fr/hal-02882190/file/2020_Vasson_J_Oncology.pdf
Autor:
Xavier Durando, Angeline Ginzac, Béatrice Morio, Judith Passildas, Catherine Abrial, Martine Duclos, Marie-Ange Mouret-Reynier, Yves Boirie, Isabelle Van Praagh, Emilie Gadéa, Emilie Thivat, Pascale Dubray-Longeras, Fabrice Kwiatkowski
Publikováno v:
Clinical Breast Cancer
Clinical Breast Cancer, Elsevier, 2018, 18 (5), pp.e1093-e1102. ⟨10.1016/j.clbc.2018.06.010⟩
Clinical Breast Cancer, 2018, 18 (5), pp.1091-1100. ⟨10.1016/j.clbc.2018.06.010⟩
Clinical Breast Cancer, Elsevier, 2018, 18 (5), pp.1091-1100. ⟨10.1016/j.clbc.2018.06.010⟩
Clinical Breast Cancer, Elsevier, 2018, 18 (5), pp.e1093-e1102. ⟨10.1016/j.clbc.2018.06.010⟩
Clinical Breast Cancer, 2018, 18 (5), pp.1091-1100. ⟨10.1016/j.clbc.2018.06.010⟩
Clinical Breast Cancer, Elsevier, 2018, 18 (5), pp.1091-1100. ⟨10.1016/j.clbc.2018.06.010⟩
Background Weight changes during adjuvant treatment for early-stage breast cancer has been associated with a poor prognosis. The long-term evolution of body composition during adjuvant treatment for breast cancer, in particular, endocrine therapy, is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f61f75d186b8d63401c4733810d850d2
https://hal.inrae.fr/hal-02959614
https://hal.inrae.fr/hal-02959614
Autor:
Isabelle Van-Praagh, Marie-Ange Mouret-Reynier, Xavier Durando, Emilie Thivat, Emilie Gadéa, Pauline Herviou, Pascale Dubray-Longeras, Martine Duclos, Angeline Ginzac, Béatrice Morio, Joyce Dohou, Marie Arbre
Publikováno v:
Nutrition and Cancer
Nutrition and Cancer, 2018, 70 (7), pp.1-10. ⟨10.1080/01635581.2018.1502330⟩
Nutrition and Cancer, Taylor & Francis (Routledge), 2018, 70 (7), pp.997-1006. ⟨10.1080/01635581.2018.1502330⟩
Nutrition and Cancer, Taylor & Francis (Routledge), 2018, 70 (7), pp.1-10. ⟨10.1080/01635581.2018.1502330⟩
Nutrition and Cancer, Taylor & Francis (Routledge), 2018, pp.1-10. ⟨10.1080/01635581.2018.1502330⟩
Nutrition and Cancer, 2018, 70 (7), pp.1-10. ⟨10.1080/01635581.2018.1502330⟩
Nutrition and Cancer, Taylor & Francis (Routledge), 2018, 70 (7), pp.997-1006. ⟨10.1080/01635581.2018.1502330⟩
Nutrition and Cancer, Taylor & Francis (Routledge), 2018, 70 (7), pp.1-10. ⟨10.1080/01635581.2018.1502330⟩
Nutrition and Cancer, Taylor & Francis (Routledge), 2018, pp.1-10. ⟨10.1080/01635581.2018.1502330⟩
International audience; In breast cancer patients, weight and fat mass changes observed after chemotherapy have been related to poor prognosis but some recent works using modern chemotherapy failed to find this correlation with weight gain. In this s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a426e8621e49658df4ecb16ad6c85934
https://hal.science/hal-01927932
https://hal.science/hal-01927932
Autor:
Aurelie Belleville, David Pérol, Laetitia Stefani, Lionel Vincent, Dominique Dramais, Emilie Lavergne, Isabelle Van Praagh-Doreau, Bernard Duvert, Ellen Blanc, Pierre-Etienne Heudel, Jean-Paul Guastalla, Anne-Claire Hardy-Bessard, Jean-Philippe Jacquin, Isabelle Cauvin
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 27(5)
Endocrine therapy (ET) used to reduce the risk of recurrence in hormone receptor-expressing disease (75% of breast cancers) is associated with worsening of climacteric symptoms with a negative impact on quality of life (QoL). Homeopathy might allow a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae054a4b752e6185e497ac97a9c024bb
https://pubmed.ncbi.nlm.nih.gov/30194492
https://pubmed.ncbi.nlm.nih.gov/30194492
Autor:
Christian François Roques, Martine Duclos, Isabelle Van Praagh-Doreau, Yves-Jean Bignon, Sylvie Jouvency, Marie-Ange Mouret-Reynier, Marie-Paule Vasson, Fabrice Kwiatkowski, Thierry Hanh, Armelle Travade, François Bridon
Publikováno v:
British Journal of Cancer
British Journal of Cancer, Cancer Research UK, 2017, 116 (11), pp.1389-1393. ⟨10.1038/bjc.2017.112⟩
British Journal of Cancer, Cancer Research UK, 2017, 116 (11), pp.1389-1393. ⟨10.1038/bjc.2017.112⟩
The trial was financed by AFRETH (French association for hydrothermal research). Auvergne Regional Council, Clermont-Communauté, League Against Cancer (Puy de Dôme committee CD63).; International audience; Background: The advantages of adapted phys
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d363a0cd71a15b6e33048f17ed3e7f79
https://hal.uca.fr/hal-01675319
https://hal.uca.fr/hal-01675319
Autor:
Fabrice Kwiatkowski, Hakim Mahammedi, Pauline Herviou, Mélanie Pouget, Isabelle Van Praagh, Joyce Dohou, Eloise Planchat, Pascale Dubray-Longeras, Hervé Devaud, Catherine Abrial, Marie Arbre, Marie-Ange Mouret-Reynier, Philippe Chollet, Xavier Durando
Publikováno v:
Oncology. 89(6)
Background: Everolimus (Afinitor®) plus exemestane are indicated for hormone receptor-positive, HER2/neu-negative metastatic breast cancer (MBC), in menopausal women without symptomatic visceral disease after recurrence or progression following arom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89187340e2ff425222a0719eb82ae502
https://pubmed.ncbi.nlm.nih.gov/26457979
https://pubmed.ncbi.nlm.nih.gov/26457979
Autor:
Hervé Curé, Pascale Dubray-Longeras, Qian Wang-Lopez, Christian Garbar, Guillaume Lebouedec, P. Chollet, Aude-Marie Savoye, Jean-Christophe Eymard, Marie-Ange Mouret-Reynier, Fabrice Kwiatkowski, Isabelle Van-Praagh, Frédérique Penault-Llorca, Catherine Abrial
Publikováno v:
The oncologist. 20(3)
Author Summary Background. Neoadjuvant treatment provides a unique opportunity to evaluate individual tumor sensitivity. This study evaluated whether a response-guided strategy could improve clinical outcome compared with a standard treatment. Method
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77e7640de56e2328834f36701147fa93
https://pubmed.ncbi.nlm.nih.gov/25637380
https://pubmed.ncbi.nlm.nih.gov/25637380